Achieve Life Sciences Inc Sustainability Reports
Achieve Life Sciences, Inc. is a late-stage clinical specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for nicotine dependence and smoking cessation.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300V82ZKZDTAU0A46
FIGI: BBG001S8JF14
4 reports from 2017 to 2024
